>

Vertex Pharmaceuticals Return on Average Equity Trend from 2010 to 2020

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>VRT</div>
VRTX -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Vertex Pharmaceuticals Return on Average Equity yearly trend continues to be fairly stable with very little volatility. Return on Average Equity will likely drop to 0.0063 in 2020. During the period from 2010 to 2020 Vertex Pharmaceuticals Return on Average Equity regression line of anual values had r squared of 0.44 and arithmetic mean of (11.49). Vertex Pharmaceuticals Weighted Average Shares is fairly stable at the moment as compared to the last year. Vertex Pharmaceuticals reported Weighted Average Shares of 228.86 Million in 2019. Income Tax Expense is likely to grow to about 16.2 M in 2020, whereas Consolidated Income is likely to drop (104.3 M) in 2020. Check Vertex Pharmaceuticals fundamental indicators over time to gain insight into the company future performance. Apply historical fundamental analysis to find patters among financial statement drivers such as Direct Expenses of 397.7 M, Cost of Revenue of 204.4 M or Gross Profit of 1.2 B, as well as many exotic indicators such as Interest Coverage of 18.07, Long Term Debt to Equity of 0.1548 or PPandE Turnover of 4.57. This can be a perfect complement to check Vertex Pharmaceuticals Valuation or Volatility. It can also complement various Vertex Pharmaceuticals Technical models. Also please take a look at analysis of Vertex Pharmaceuticals Correlation with competitors.

Vertex Pharmaceuticals Return on Average Equity Marginal Breakdown

Showing smoothed Return on Average Equity of Vertex Pharmaceuticals Incorpor with missing and latest data points interpolated. Return on equity measures a corporation's profitability by calculating the amount of [NetIncCmn] returned as a percentage of [EquityAvg].
View

0.63 

          10 Years Trend
Increasing
Slightly volatile
 Return on Average Equity 
    
  Timeline 

Vertex Pharmaceuticals Regression Statistics

Arithmetic Mean(11.49)
Geometric Mean 13.53
Coefficient Of Variation(424.62)
Mean Deviation 36.84
Median(10.69)
Standard Deviation 48.77
Sample Variance 2,378
Range 159.19
R Value 0.67
Mean Square Error 1,473
R Squared 0.44
Significance 0.02547
Slope 9.78
Total Sum of Squares 23,783

Vertex Pharmaceuticals Return on Average Equity Over Time

2018  64.88 
2019  58.39 
2020  0.0063